Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1306 AL 1320

The prevalence and clinical characteristics of pathological gambling in Parkinson's disease: an evidence-based review

Barns Neurauter MP, Rickards H, Cavanna AE.

Funct Neurol. 2010 Jan-Mar;25(1):9-13.

Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders

Antonini A, Bernardi L, Calandrella D, Mancini F, Plebani M.

Funct Neurol. 2010 Jan-Mar;25(1):21-5.

An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay

Bonnici A, Ruiner CE, St-Laurent L, Hornstein D.

Ann Pharmacother. 2010 Sep;44(9):1504-7. doi: 10.1345/aph.1P242. Epub 2010 Jul 13.

Vitamin D and ageing: neurological issues

Annweiler C, Schott AM, Berrut G, Chauviré V, Le Gall D, Inzitari M, Beauchet O.

Neuropsychobiology. 2010 Aug;62(3):139-50. doi: 10.1159/000318570. Epub 2010 Jul 14.

Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease

Gondim Fde A, Costa HA, Taunay TC, de Oliveira GR, Ferreira JM, Rola FH.

Mov Disord. 2010 Jul 30;25(10):1505-6. doi: 10.1002/mds.22553.

Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia

Lai SC, Jung SM, Grattan-Smith P, Sugo E, Lin YW, Chen RS, Chen CC, Wu-Chou YH, Lang AE, Lu CS.

Mov Disord. 2010 Jul 15;25(9):1274-9. doi: 10.1002/mds.22876.

Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism?

Vilensky JA, Gilman S, McCall S.

Mov Disord. 2010 Jul 15;25(9):1124-30. doi: 10.1002/mds.22991.

The effects of an exercise program on fall risk factors in people with Parkinson's disease: a randomized controlled trial

Allen NE, Canning CG, Sherrington C, Lord SR, Latt MD, Close JC, O'Rourke SD, Murray SM, Fung VS.

Mov Disord. 2010 Jul 15;25(9):1217-25. doi: 10.1002/mds.23082.

Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study

Mizuno Y, Hasegawa K, Kondo T, Kuno S, Yamamoto M; Japanese Istradefylline Study Group.

Mov Disord. 2010 Jul 30;25(10):1437-43. doi: 10.1002/mds.23107.

Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review

Alonso-Canovas A, Katschnig P, Tucci A, Carecchio M, Wood NW, Edwards M, Martínez Castrillo JC, Burke D, Heales S, Bhatia KP.

Mov Disord. 2010 Jul 30;25(10):1506-9. doi: 10.1002/mds.23109.

Pallidopyramidal disease: a misnomer?

Horstink MW, Dekker MC, Montagna P, Bonifati V, van De Warrenburg BP.

Mov Disord. 2010 Jul 15;25(9):1109-15. doi: 10.1002/mds.23118.

Primary progressive freezing gait in a patient with CO-induced parkinsonism

Lee MS, Lyoo CH, Choi YH.

Mov Disord. 2010 Jul 30;25(10):1513-5. doi: 10.1002/mds.23124.

Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease

Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G.

Mov Disord. 2010 Jul 15;25(9):1183-9. doi: 10.1002/mds.23127.

Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease

Gierthmühlen J, Arning P, Binder A, Herzog J, Deuschl G, Wasner G, Baron R.

Mov Disord. 2010 Jul 15;25(9):1195-202. doi: 10.1002/mds.23128.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias